STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS AFTER VACCINATION: REPORTS TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM
Robert Ball(Center for Drug Evaluation and Research), Marcel E. Salive(National Institute on Aging), Robert P. Wise(Center for Biologics Evaluation and Research), Judy A. Beeler(Center for Biologics Evaluation and Research), L. Ball(Center for Biologics Evaluation and Research), M. Miles Braun(Center for Biologics Evaluation and Research)
Cited by 84
Related Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
|New England Journal of Medicine|2001|3.7k
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
|Arthritis & Rheumatism|2002|661
Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey
|American Journal of Kidney Diseases|1998|575
Multimorbidity in Older Adults With Cardiovascular Disease
|Journal of the American College of Cardiology|2018|475
Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist
|Annals of Internal Medicine|2003|459